[Therapeutic effects of macrolides on patients with palmoplantar pustulosis].
Matsunaga
Y
Y
Katayama
I
I
Monden
J
J
D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000494:pharmacology; D002478:Cells, Cultured; D017291:Clarithromycin / Q000008:administration & dosage* / Q000494:pharmacology; D016207:Cytokines / Q000276:immunology; D004917:Erythromycin / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D016209:Interleukin-8 / Q000378:metabolism; D015603:Keratinocytes / Q000276:immunology; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy*; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D016207:Cytokines; D016209:Interleukin-8; D004917:Erythromycin; D017291:Clarithromycin